Find a Doctor Search
Dr. Bruce Wenig is a Senior Member in the Department of Anatomic Pathology at Moffitt Cancer Center. Dr. Wenig also serves as the Section Head of Anatomic Pathology External Network Consultation Services and the Section Head of Moffitt’s Head and Neck–Endocrine Pathology Program. Dr. Wenig received his MD from Sackler School of Medicine/New York State Division at the Tel Aviv University in Israel. He completed an Anatomic and Clinical Pathology Residency in the Department of Pathology at The Mount Sinai Medical Center, New York. Dr. Wenig completed a Fellowship in Surgical Pathology in the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, Los Angeles, California, and a Fellowship in Otolaryngic Pathology at the Armed Forces Institute of Pathology in Washington, DC. Following his Fellowship, Dr. Wenig was a Staff Pathologist (1987-1998) for the Department of Otolaryngic-Endocrine Pathology at the Armed Forces Institute of Pathology, and also served as Chief, Division of Otolaryngic Pathology, Department of Endocrine and Otorhinolaryngic Head and Neck Pathology, Washington, DC. From 1998 to 2001, Dr. Wenig was the Vice Chairman for Anatomic Pathology and Professor of Pathology, Department of Pathology at Albert Einstein College of Medicine, Bronx, NY. From 2001 to 2003, he was Vice Chairman for Anatomic Pathology, Department of Pathology and Laboratory Medicine at Beth Israel Medical Center, St. Luke’s – Roosevelt Hospitals, New York, NY, and Associate Director, Continuum Cancer Center of New York. Prior to joining Moffitt, he was the Chairman, Department of Diagnostic Pathology and Laboratory Medicine, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai Roosevelt, New York; Vice Chairman of Anatomic Pathology, Department of Pathology, Mount Sinai Health System, NY; and Professor of Pathology, Department of Pathology, Icahn School of Medicine, Mount Sinai, NY. Dr. Wenig’s main clinical interests are in diseases of the head and neck and of endocrine organs including oncologic and non-neoplastic diseases. He has published extensively in peer-reviewed journals as well as authoring/editing several textbooks and numerous book chapters on head-and-neck and endocrine pathology. The third edition of his singly authored book, The Atlas of Head and Neck Pathology, was published in 2016. His research is primarily clinically focused, utilizing classic morphology in conjunction with immunohistochemical and molecular biologic techniques in the evaluation of a wide spectrum of diseases of the head and neck and of the endocrine organs.
Education & Training
- Anatomic Pathology & Clinical Pathology
- Cedars-Sinai Medical Center - Anatomic Pathology
- Amred Forces Institute of Pathology - Otolaryngic Pathology
- The Mount Sinai Medical Center - Anatomic Pathology
- Sackler School of Medicine/NY Division at Tel Aviv University - MD
If you believe you are eligible for one of these trials or studies, please call
- Stelow EB, Wenig BM. Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx. Head Neck Pathol. 2017 Mar;11(1):16-22. Pubmedid: 28247232. Pmcid: PMC5340728.
- Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants. Mod Pathol. 2017 Jan;30(s1):S112-S118. Pubmedid: 28060368.
- Valderrabano P, Khazai L, Thompson ZJ, Leon ME, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B. Cancer risk stratification of indeterminate thyroid nodules: A cytological approach. Thyroid. 2017 Aug. Pubmedid: 28806881.
- Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016 Aug;2(8):1023-1029. Pubmedid: 27078145. Pmcid: PMC5539411.
- Isayeva T, Xu J, Ragin C, Dai Q, Cooper T, Carroll W, Dayan D, Vered M, Wenig B, Rosenthal E, Grizzle W, Anderson J, Willey CD, Yang ES, Brandwein-Gensler M. The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways. Mod Pathol. 2015 May;28(5):631-653. Pubmedid: 25523612.